Robert G. Petit

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang et al. · Cell · 2020 · 536 citations · Full text

Life Sciences, Immunology, Oncology +16

A Randomized Phase 2 Study of ADXS11-001 Listeria monocy'togenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer

Partha Basu, Ajay Mehta, Minish Jain et al. · International Journal of Gynecological Cancer · 2018 · 178 citations · Full text

Medicine, Immunology, Oncology +17

Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer

Daniel O. Villarreal, Andrew L'Huillier, Susan Armington et al. · Cancer Research · 2018 · 139 citations

Life Sciences, Immunology, Oncology +17

Randomized, placebo‐controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline‐based chemotherapy

Douglas E. Peterson, James B. Jones, Robert G. Petit · Cancer · 2006 · 136 citations

Pharmacy, Oncology, Pharmacology +15

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

Andréa Toma, Olivier Kosmider, Sylvie Chevret et al. · Leukemia · 2015 · 121 citations · Full text

Medicine, Hematology, Pharmacotherapy +9